ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001745961

Versant Voyageurs I Parallel, L.P.

CIK 0001745961 Name as filed on the most recent filing

Filed as Versant Voyageurs I Parallel, L.P. (18)

77 transaction lines · from 18 filings · filed 2020-02-05 to 2024-08-30 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2024-08-28 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 221,600 disposed 6.32 1,400,556.32 Form 4, filing 0000950170-24-102354
2022-01-03 Chinook Therapeutics, Inc.
KDNY 		S, Open-market sale 600,000 disposed 16.00 9,600,120.00 Form 4, filing 0000899243-22-000946
2022-01-03 Chinook Therapeutics, Inc.
KDNY 		S, Open-market sale 308,000 disposed 16.00 4,928,061.60 Form 4, filing 0000899243-22-000946
2022-01-03 Chinook Therapeutics, Inc.
KDNY 		S, Open-market sale 92,000 disposed 16.00 1,472,018.40 Form 4, filing 0000899243-22-000946
2021-08-27 Chinook Therapeutics, Inc.
KDNY 		S, Open-market sale 510,000 disposed 14.00 7,140,000.00 Form 4, filing 0000899243-21-034627
2021-08-27 Chinook Therapeutics, Inc.
KDNY 		S, Open-market sale 261,902 disposed 14.00 3,666,628.00 Form 4, filing 0000899243-21-034627
2021-08-27 Chinook Therapeutics, Inc.
KDNY 		S, Open-market sale 78,098 disposed 14.00 1,093,372.00 Form 4, filing 0000899243-21-034627
2020-11-30 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 10,193 disposed 33.13 337,679.82 Form 4, filing 0000899243-20-032389
2020-11-30 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 200 disposed 34.16 6,832.92 Form 4, filing 0000899243-20-032389
2020-11-19 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 114,854 disposed 33.01 3,791,330.54 Form 4, filing 0000899243-20-031918
2020-11-19 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 15,163 disposed 33.01 500,530.63 Form 4, filing 0000899243-20-031918
2020-11-18 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 473 disposed 33.09 15,653.37 Form 4, filing 0000899243-20-031771
2020-11-18 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 63 disposed 33.09 2,084.91 Form 4, filing 0000899243-20-031771
2020-11-17 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 3,705 disposed 33.05 122,449.51 Form 4, filing 0000899243-20-031771
2020-11-17 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 489 disposed 33.05 16,161.35 Form 4, filing 0000899243-20-031771
2020-11-16 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 177 disposed 33.01 5,843.21 Form 4, filing 0000899243-20-031322
2020-11-16 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 23 disposed 33.01 759.29 Form 4, filing 0000899243-20-031322
2020-11-13 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 2,473 disposed 33.31 82,387.75 Form 4, filing 0000899243-20-031322
2020-11-13 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,502 disposed 34.53 51,865.41 Form 4, filing 0000899243-20-031322
2020-11-13 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 327 disposed 33.31 10,893.97 Form 4, filing 0000899243-20-031322
2020-11-13 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 198 disposed 34.53 6,837.12 Form 4, filing 0000899243-20-031322
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 9,450 disposed 34.39 325,011.96 Form 4, filing 0000899243-20-031061
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 3,976 disposed 33.48 133,106.14 Form 4, filing 0000899243-20-031061
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,248 disposed 34.39 42,922.21 Form 4, filing 0000899243-20-031061
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 524 disposed 33.48 17,542.16 Form 4, filing 0000899243-20-031061
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 353 disposed 35.15 12,407.53 Form 4, filing 0000899243-20-031061
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 47 disposed 35.15 1,651.99 Form 4, filing 0000899243-20-031061
2020-11-11 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 9,027 disposed 34.94 315,378.10 Form 4, filing 0000899243-20-030855
2020-11-11 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 2,119 disposed 33.86 71,748.49 Form 4, filing 0000899243-20-030855
2020-11-11 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,191 disposed 34.94 41,610.21 Form 4, filing 0000899243-20-030855
2020-11-11 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 280 disposed 33.86 9,480.69 Form 4, filing 0000899243-20-030855
2020-11-10 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 12,433 disposed 34.14 424,509.87 Form 4, filing 0000899243-20-030855
2020-11-10 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 11,388 disposed 33.48 381,245.19 Form 4, filing 0000899243-20-030855
2020-11-10 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,642 disposed 34.14 56,064.12 Form 4, filing 0000899243-20-030855
2020-11-10 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,503 disposed 33.48 50,317.13 Form 4, filing 0000899243-20-030855
2020-11-09 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 5,565 disposed 33.06 183,954.41 Form 4, filing 0000899243-20-030745
2020-11-09 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 735 disposed 33.06 24,295.87 Form 4, filing 0000899243-20-030745
2020-11-06 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 2,738 disposed 33.13 90,705.83 Form 4, filing 0000899243-20-030745
2020-11-06 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 362 disposed 33.13 11,992.52 Form 4, filing 0000899243-20-030745
2020-11-05 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 7,816 disposed 33.15 259,079.30 Form 4, filing 0000899243-20-030580
2020-11-05 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,032 disposed 33.15 34,208.01 Form 4, filing 0000899243-20-030580
2020-11-04 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 2,208 disposed 33.14 73,163.63 Form 4, filing 0000899243-20-030580
2020-11-04 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 292 disposed 33.14 9,675.62 Form 4, filing 0000899243-20-030580
2020-10-27 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 707 disposed 33.03 23,353.98 Form 4, filing 0000899243-20-029546
2020-10-27 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 93 disposed 33.03 3,072.02 Form 4, filing 0000899243-20-029546
2020-10-26 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 7,158 disposed 33.30 238,394.33 Form 4, filing 0000899243-20-029546
2020-10-26 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 945 disposed 33.30 31,472.85 Form 4, filing 0000899243-20-029546
2020-10-19 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 3,739 disposed 33.43 124,998.14 Form 4, filing 0000899243-20-028811
2020-10-19 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 494 disposed 33.43 16,514.86 Form 4, filing 0000899243-20-028811
2020-10-16 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 7,697 disposed 33.57 258,409.84 Form 4, filing 0000899243-20-028811

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Versant Voyageurs I Parallel, L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001745961

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.